Keara M. Lane

发表

Deep Learning Automates the Quantitative Analysis of Individual Cells in Live-Cell Imaging Experiments

Euan A. Ashley, Markus W. Covert, David A. Van Valen, 2016, PLoS Comput. Biol..

Simultaneous cross-evaluation of heterogeneous E. coli datasets via mechanistic simulation

Keara M. Lane, Derek N. Macklin, Mialy M. DeFelice, 2020, Science.

Combinatorial processing of bacterial and host-derived innate immune stimuli at the single-cell level

Keara M. Lane, M. Covert, D. Amatya, 2019, Molecular biology of the cell.

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

Keara M. Lane, David Housman, Helen Conroy, 2003, Genes, chromosomes & cancer.

ROS1 signaling regulates epithelial differentiation in the epididymis.

Keara M. Lane, R. Bronson, Levi B. Wood, 2014, Endocrinology.

IMPAIRED SHP2-MEDIATED ERK ACTIVATION CONTRIBUTES TO GEFITINIB SENSITIVITY OF LUNG CANCER CELLS WITH EGFR-ACTIVATING MUTATIONS

Keara M. Lane, P. Sorger, T. Jacks, 2010 .

Navigating Environmental Transitions: the Role of Phenotypic Variation in Bacterial Responses

Keara M. Lane, Madison R. Spratt, 2022, mBio.

Mechanically resolved imaging of bacteria using expansion microscopy

Keara M. Lane, K. Ng, K. C. Huang, 2019, bioRxiv.

Escalating Threat Levels of Bacterial Infection Can Be Discriminated by Distinct MAPK and NF-κB Signaling Dynamics in Single Host Cells.

Keara M. Lane, M. Covert, D. Monack, 2019, Cell systems.

Simultaneous cross-evaluation of heterogeneous E. coli datasets via mechanistic simulation

Markus W. Covert, Keara M. Lane, Derek N. Macklin, 2019, Science.

Measuring Signaling and RNA-Seq in the Same Cell Links Gene Expression to Dynamic Patterns of NF-κB Activation.

Takamasa Kudo, Keara M. Lane, Derek N. Macklin, 2017, Cell systems.

Dicer1 functions as a haploinsufficient tumor suppressor.

Keara M. Lane, T. Golub, Jun Lu, 2009, Genes & development.

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.

Keara M. Lane, D. Housman, M. Yaffe, 2006, Cancer research.

functions as a haploinsufficient tumor suppressor Dicer 1 Material Supplemental

Keara M. Lane, T. Golub, Jun Lu, 2009 .

Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.

Keara M. Lane, D. Lauffenburger, P. Sorger, 2010, Cancer research.

Impaired SHP 2-Mediated Extracellular Signal-Regulated Kinase Activation Contributes to Gefitinib Sensitivity of Lung Cancer Cells with Epidermal Factor Receptor-Citation

Keara M. Lane, D. Lauffenburger, P. Sorger, 2010 .

Measuring Signaling and R NA-Seq in the Same Cell Links Gene Expression to Dynamic Patterns of NFk B Activation Graphical Abstract Highlights

Keara M. Lane, Derek N. Macklin, Mialy M. DeFelice, 2017 .

Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas.

Keara M. Lane, D. Housman, R. Bronson, 2009, Cancer research.

Association of a Novel PDZ Domain-containing Peripheral Golgi Protein with the Q-SNARE (Q-solubleN-Ethylmaleimide-sensitive Fusion Protein (NSF) Attachment Protein Receptor) Protein Syntaxin 6*

Keara M. Lane, D. Housman, K. McMahon, 2001, Journal of Biological Chemistry.

Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma

Keara M. Lane, D. Housman, Julie Park, 2003, Proceedings of the National Academy of Sciences of the United States of America.

A multiplexed epitope barcoding strategy that enables dynamic cellular phenotypic screens.

Keara M. Lane, M. Covert, Takamasa Kudo, 2022, Cell systems.

Mouse models of human non-small-cell lung cancer: raising the bar.

Keara M. Lane, A. Sweet-Cordero, T. Jacks, 2005, Cold Spring Harbor symposia on quantitative biology.

Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.

Keara M. Lane, D. Lauffenburger, P. Sorger, 2010, Cancer research.